Here are five key notes:
1. The device, called the ReShape Integrated Dual Balloon System is designed to facilitate weight loss in adult patients.
2. The device is delivered into the stomach via the mouth through a minimally invasive outpatient endoscopic procedure. Once in place, the device is inflated with a sterile solution.
3. However, potential side effects for the procedure include headache, muscle pain and nausea from the sedation and procedure and in rare cases even heart attack.
4. The device should not be used for certain patients, including those who have had previous gastrointestinal or bariatric surgery.
5. The ReShape Dual Balloon is manufactured by ReShape Medical.
More articles on ASC news:
11 things to know about ASC quality reporting
Apex Surgical Center opens in New York: 5 key points
ASC efficiency: Best strategies to overcome today’s toughest challenges
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
